Obesity as a medical problem


Obesity is now so common within the world's population that it is beginning to replace undernutrition and infectious diseases as the most significant contributor to ill health. In particular, obesity is associated with diabetes mellitus, coronary heart disease, certain forms of cancer, and sleep-breathing disorders. Obesity is defined by a body-mass index (weight divided by square of the height) of 30 kg m−2 or greater, but this does not take into account the morbidity and mortality associated with more modest degrees of overweight, nor the detrimental effect of intra-abdominal fat. The global epidemic of obesity results from a combination of genetic susceptibility, increased availability of high-energy foods and decreased requirement for physical activity in modern society. Obesity should no longer be regarded simply as a cosmetic problem affecting certain individuals, but an epidemic that threatens global well being.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Relation between BMI up to 30 and the relative risk of type 2 diabetes, hypertension, CHD and cholelithiasis.
Figure 2

Courtesy of the International Obesity Task Force.

Figure 3


  1. 1

    Kopelman, P. G. Causes and consequences of obesity. Med. Int. 22, 385–388 (1994).

    Google Scholar 

  2. 2

    Society of Actuaries. Build Study of 1979 (Recording and Statistical Corporation, 1980).

  3. 3

    Lew, E. A. Mortality and weight: insured lives and the American Cancer Study. Annals of Intern. Med. 103, 1024–1029 (1985).

    CAS  Article  Google Scholar 

  4. 4

    Hubert, H. B. The importance of obesity in the development of coronary risk factors and disease: the epidemiological evidence. Annu. Rev. Public Health 7, 493–502 ( 1986).

    CAS  Article  Google Scholar 

  5. 5

    World Health Organization Expert Committee. Physical Status: The Use and Interpretation of Anthropometry, WHO Tech. Rep. Ser. no. 854 (World Health Organization, Geneva, 1995).

  6. 6

    World Health Organization. Obesity: Preventing and Managing the Global Epidemic (World Health Organization, Geneva, 1997).

  7. 7

    Manson, J. E. et al. Body weight and mortality among women. N. Engl. J. Med. 333, 677–685 ( 1995).

    CAS  Article  Google Scholar 

  8. 8

    Willett, W. C. et al. Weight, weight change, and coronary heart disease in women: risk within the “normal” weight range. J. Am. Med. Assoc. 273, 461–465 ( 1995).

    CAS  Article  Google Scholar 

  9. 9

    Willett, W. C., Dietz, W. H. & Colditz, G. A. Guidelines for healthy weight. N. Engl. J. Med. 341, 427–433 ( 1999).

    CAS  Article  Google Scholar 

  10. 10

    Han, T. S., van Leer, E. M., Seidell, J. C. & Lean, M. E. J. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. Br. Med. J. 311, 1401–1405 ( 1995).

    CAS  Article  Google Scholar 

  11. 11

    Seidell, J. C. The impact of obesity on health status: some implications for health care costs. Int. J. Obesity 19(Suppl. 6), S13–S16 (1996).

    Google Scholar 

  12. 12

    McKeigue, P. M., Shah, B. & Marmot, M. G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337, 382–386 ( 1991).

    CAS  Article  Google Scholar 

  13. 13

    Kotani, K. et al. Two decades of annual medical examinations in Japanese obese children: do obese children grow into obese adults? Int. J. Obesity 21, 912–921 ( 1997).

    CAS  Article  Google Scholar 

  14. 14

    Dietz, W. H. Critical periods in childhood for the development of obesity. Am. J. Clin. Nutr. 59, 829–840 (1994).

    Google Scholar 

  15. 15

    World Health Organization MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35–64 years. World Health Stat. Quart. 41 , 115–140 (1988).

  16. 16

    Prescott-Clarke, P. & Primatesta, P. Health Survey for England 1996 (HMSO, London, 1998).

    Google Scholar 

  17. 17

    Kuczmarski, R. J. et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys 1960 to 1991. J. Am. Med. Assoc. 272, 205–211 ( 1994).

    CAS  Article  Google Scholar 

  18. 18

    Forrester, T. et al. in The Origins and Consequences of Obesity (eds Chadwick, D. J. & Cardeau, G.) 17–31 (Wiley, Chichester, 1996).

    Google Scholar 

  19. 19

    Popkin, B. M. The nutrition transition in low-income countries — an emerging crisis . Nutr. Rev. 52, 285–298 (1994).

    CAS  Article  Google Scholar 

  20. 20

    Hodge, A. M. et al. Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations. Obesity Res. 3( Suppl. 2), 77s–87s (1995 ).

    Article  Google Scholar 

  21. 21

    Musaiger, A. in Diet-Related Non-communicable Diseases in the Arab Countries of the Gulf. (eds Musaiger, A. O. & Miladi, S. S.) 99–117 (Food and Agriculture Organisation of the United Nations, Cairo, 1996).

    Google Scholar 

  22. 22

    Bouchard, C. et al. The response to long term overfeeding in identical twins. N. Engl. J. Med. 322, 1477–1482 (1990).

    CAS  Article  Google Scholar 

  23. 23

    Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue . Nature 372, 425–432 (1994).

    ADS  CAS  Article  Google Scholar 

  24. 24

    Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. & Burn, P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 280, 546–549 (1995).

    ADS  Article  Google Scholar 

  25. 25

    Maffei, M. et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Med. 11, 1155–1161 (1995).

    Article  Google Scholar 

  26. 26

    Farooqi, I. S. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879–884 (1999).

    CAS  Article  Google Scholar 

  27. 27

    Prentice, A. M., Black, A. E., Coward, W. A. & Cole, T. J. Energy expenditure in affluent societies: an analysis of 319 doubly-labelled water measurements. Eur. J. Clin. Nutr. 50, 93–97 (1996).

    CAS  PubMed  Google Scholar 

  28. 28

    Ravussin, E. et al. Reduced rate of expenditure as a risk factor for body weight . N. Engl. J. Med. 318, 467– 472 (1988).

    CAS  Article  Google Scholar 

  29. 29

    Seidell, J., Muller, D., Sorkin, J. & Andres, R. Fasting respiratory exchange ratio and resting metabolic rates as predictors of weight gain: The Baltimore Longitudinal Study on Ageing. Int. J. Obesity 16, 667–674 (1992).

    CAS  Google Scholar 

  30. 30

    Ferro-Luzzi, A. & Martino, L. in The Origins and Consequences of Obesity (eds Chadwick, D. & Cardew, G.) 207–227 (Wiley, Chichester, 1996).

    Google Scholar 

  31. 31

    Rissanen, A. et al. Determinants of weight gain and overweight in adult Finns . Eur. J. Clin. Nutr. 45, 419– 430 (1991).

    CAS  PubMed  Google Scholar 

  32. 32

    Gormaker, S. et al. Television viewing as a cause of increasing obesity among children in the United States. Arch. Pediatr. Adolesc. Med. 150, 356–362 (1996).

    Article  Google Scholar 

  33. 33

    Prentice, A. M. & Jebb, S. A. Obesity in Britain: gluttony or sloth? Br. Med. J. 311, 437– 439 (1995).

    CAS  Article  Google Scholar 

  34. 34

    Lichtman, S. et al. Discrepancy between self-reported and actual calorie intake and exercise in obese subjects. N. Engl. J. Med. 327 , 1893–1898 (1993).

    Article  Google Scholar 

  35. 35

    Poppitt, S. D., Swann, D., Black, A. E. & Prentice, A. M. Assessment of selective under-reporting of food intake by both obese and non-obese women in metabolic facility. of Int. J. Obesity 22, 303–311 (1998).

    CAS  Article  Google Scholar 

  36. 36

    Lawton, C., Burley, V., Wales, J. & Blundell, J. Dietary fat and appetite control in obese subjects: weak effects on satiation and satiety . Int. J. Obesity 17, 409– 416 (1993).

    CAS  Google Scholar 

  37. 37

    Blundell J. E. & Macdiarmid, J. I. Passive overconsumption: fat intake and short term energy balance. Ann. NY Acad. Sci. 827, 392–407 (1997).

    ADS  CAS  Article  Google Scholar 

  38. 38

    James, W. in The Origins and Consequences of Obesity (eds Chadwick, D. & Cardew, G.) 1–16 (Wiley, Chichester, 1996).

    Google Scholar 

  39. 39

    Ravussin, E. Metabolic differences and the development of obesity. Metabolism 9(Suppl. 3), 12–14 (1995).

    Article  Google Scholar 

  40. 40

    Wilks, R. et al. in The Origins and Consequences of Obesity (eds Chadwick, D. & Cardew, G.) 37–53 (Wiley, Chichester, 1996).

    Google Scholar 

  41. 41

    Bennett, N., Dodd, T., Flatley, J., Freeth, S. & Bolling, K. Health Survey for England 1993 (HMSO, London, 1995).

    Google Scholar 

  42. 42

    Barker, D. J. P. Fetal origins of coronary heart disease. Br. Med. J. 311, 171–174 (1995).

    CAS  Article  Google Scholar 

  43. 43

    Barker, D. J. P. et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br. Med. J. 298, 654–657 ( 1989).

    Article  Google Scholar 

  44. 44

    Hales, C. N. et al. Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J. 303, 1019– 1022 (1991).

    CAS  Article  Google Scholar 

  45. 45

    Ravelli, J.-P., Stein, Z. A. & Susser, M. W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349–353 (1976).

    CAS  Article  Google Scholar 

  46. 46

    Kolterman, O. G., Insel, J., Sackow, M. & Olefsky, M. Mechanisms of insulin resistance in human obesity. J. Clin. Invest. 65, 1272–1284 (1980).

    CAS  Article  Google Scholar 

  47. 47

    Reynisdottir, S., Ellerfeldt, K., Wahrenberg, H., Lithell, H. & Arner, P. Multiple lipolysis defects in insulin resistance [metabolic] syndrome. J. Clin. Invest. 93 , 2590–2599 (1994).

    CAS  Article  Google Scholar 

  48. 48

    Lonnquist, F., Thorne, A., Nilsell, K., Hoffstedt, J. & Arner, P. A pathogenic role of visceral fat β3-adrenoceptors in obesity. J. Clin. Invest. 95, 1109– 1116 (1995).

    Article  Google Scholar 

  49. 49

    Frayn, K. N., Williams, C. M. & Arner, P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin. Sci. 90, 243–253 ( 1996).

    CAS  Article  Google Scholar 

  50. 50

    Sniderman, A. & Cainflone, K. Metabolic disruptions in the adipocyte-hepatocyte fatty acid axis as the cause of hyperapoB. Int. J. Obesity 19(Suppl. 1), S27–S33 ( 1995).

    Google Scholar 

  51. 51

    Colditz, G. A., Willett, W. C., Rotnitsky, A. & Manson, J. E. Weight gain as a risk factor for clinical diabetes in women. Arch. Int. Med. 122, 481–486 ( 1995).

    CAS  Google Scholar 

  52. 52

    Chan, J. M. et al. Obesity, fat distribution and weight gain as riskfactors for clinical diabetes in men. Diabetes Care 17, 961–969 (1994).

    CAS  Article  Google Scholar 

  53. 53

    Lean, M. E. J., Hans, T. S. & Seidell, J. C. Impairment of health and quality life in people with large waist circumference. Lancet 351, 853 –856 (1998).

    CAS  Article  Google Scholar 

  54. 54

    Masserli, F. H. et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 66, 55–60 (1982).

    Article  Google Scholar 

  55. 55

    De Divitiis, O. et al. Obesity and cardiac function. Circulation 64, 477–482 (1981).

    CAS  Article  Google Scholar 

  56. 56

    Licata, G. et al. Effect of obesity on left ventricular function studied by radionuclide angiography. Int. J. Obesity 15, 295–302 (1991).

    CAS  Google Scholar 

  57. 57

    Lauer, M. S., Anderson, K. M., Kannel, W. B. & Levy, D. The impact of obesity on left ventricular mass and geometry. J. Am. Med. Assoc. 266, 231–236 (1991).

    CAS  Article  Google Scholar 

  58. 58

    de la Maza, M. et al. Ventricular mass in hypertensive and normotensive obese subjects . Int. J. Obesity 18, 193– 197 (1994).

    CAS  Google Scholar 

  59. 59

    Garavaglia, G. E. et al. Myocardial contractility and left ventricular function in obese patients with essential hypertension. Am. J. Cardiol. 62, 594–597 (1988).

    CAS  Article  Google Scholar 

  60. 60

    Hubert, H. B., Feinleib, M., McNamara, P. M. & Castelli, W. P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 67, 968–977 ( 1983).

    CAS  Article  Google Scholar 

  61. 61

    Willet, W. C. et al. Weight, weight change and coronary heart disease in women . J. Am. Med. Assoc. 273, 461– 465 (1995).

    Article  Google Scholar 

  62. 62

    Kopelman, P. G. Sleep apnoea and hypoventilation in obesity. Int. J. Obesity 16(Suppl. 2), S37–S42 ( 1992).

    Google Scholar 

  63. 63

    Grunstein, R. R. in Clinical Obesity (eds Kopelman, P. G. & Stock, M. J.) 248–289 (Blackwell Science, Oxford, 1998).

    Google Scholar 

  64. 64

    Kopelman, P. G., Apps, M. C. P., Cope, T. & Empey, D. W. Nocturnal hypoxia and sleep apnoea in asymptomatic men. Int. J. Obesity 10, 211–217 (1986).

    CAS  Google Scholar 

  65. 65

    Kopelman, P. G., Apps, M. C. P., Cope, T. & Empey, D. W. The influence of menstrual status, body weight and hypothalamic function on nocturnal respiration in women. J. R. Coll. Physicians Lond. 19, 243–247 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  66. 66

    Rochester, D. F. & Eaton, Y. Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Mechanical and circulatory factors. Am. J. Med. 57, 402 –420 (1974).

    CAS  Article  Google Scholar 

  67. 67

    Grunstein, R. R., Stenlof, K., Hedner, J. & Sjostrom, L. Impact of obstructive apnoea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int. J. Obesity 19, 410–418 (1995).

    CAS  Google Scholar 

  68. 68

    Palomaki, H., Partinen, M., Erkinjuntti, T. & Kaste, M. Snoring, sleep apnoea syndrome and stroke. Neurology 42(Suppl. 6), 75–81 ( 1992).

    CAS  PubMed  Google Scholar 

  69. 69

    Rose, G. Population distribution of risk and disease. Nutr. Metabol. Cardiovascular Dis. 1, 37–40 ( 1991).

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Peter G. Kopelman.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kopelman, P. Obesity as a medical problem. Nature 404, 635–643 (2000). https://doi.org/10.1038/35007508

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing